Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Citius Pharmaceuticals Inc (CTXR) – Citius Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Global digital pens market to grow at 13.3% CAGR, reaching $5.3B by 2032 driven by tech advances and digital workflows.

The global digital pens market, valued at $2.2 billion in 2025, is projected to reach $5.3 billion by 2032 with a 13.3% CAGR. Growth is fueled by increased adoption in education and corporate sectors, technological improvements like pressure sensitiv...

Market News
41 minutes ago
Researchandmarkets.Com
Bullish
news icon
pluang ai news

Industrial laser market to grow 5.8% CAGR, reaching $10.94B by 2031, led by APAC and semiconductor sectors.

The global industrial laser market is projected to grow at a 5.8% CAGR from 2025 to 2031, reaching $10.94 billion by 2031. Medium power lasers, especially CO₂ types, currently dominate, with the semiconductor and electronics sector showing the fastes...

Market News
43 minutes ago
Researchandmarkets.Com
Bullish
news icon
pluang ai news

Geely Preface TCR wins first race at FIA TCR World Tour in Misano, marking a historic motorsport milestone.

Geely Auto Group achieved its first-ever victory with the all-new Geely Preface TCR at the FIA TCR World Tour held at the Misano World Circuit in Italy. Chinese driver Ma Qinghua secured the win in Race 2 after a strategic move on lap six, showcasing...

Market News
47 minutes ago
Na
Bullish
news icon
pluang ai news

Geely Preface TCR wins first race at FIA TCR World Tour in Misano, marking a historic motorsport milestone.

Geely Auto Group achieved its first-ever victory in global motorsports with the all-new Geely Preface TCR at the FIA TCR World Tour held at Misano Circuit, Italy. Chinese driver Ma Qinghua secured the win in Race 2, starting third and taking the lead...

Market News
1 hour ago
Na
Bullish
news icon
pluang ai news

Cancer biomarkers market to reach $35.16B by 2031, driven by precision oncology and early detection demand.

The global cancer biomarkers market is projected to grow from $23.22 billion in 2026 to $35.16 billion by 2031, at a CAGR of 8.65%. Growth is fueled by rising cancer prevalence, increased use of personalized medicine, and advances in molecular diagno...

Market News
2 hours ago
Mordor Intelligence
Bullish
news icon
pluang ai news

Organic semiconductor market to reach $1.18 trillion by 2035 with 20.35% CAGR driven by energy-efficient tech.

The global organic semiconductor market, valued at $184.52 billion in 2025, is projected to grow to $1,175.68 billion by 2035, expanding at a CAGR of 20.35%. Growth is fueled by advances in molecular stacking that enhance energy efficiency and bright...

Market News
2 hours ago
Sns Insider
Bullish
news icon
pluang ai news

Pension officials criticize SpaceX's IPO structure as overly favorable to Elon Musk's control.

Top pension officials from New York and California have expressed concerns about SpaceX's upcoming IPO, criticizing its dual-class share structure that grants Elon Musk significant voting power and control. They warn that this 'most management-favora...

Market News
2 hours ago
Badar Shaikh
Bearish
news icon
pluang ai news

Ipsen presents corabotase, a novel neuro-inhibitor, showing promising phase II results for facial wrinkle treatment.

Ipsen has introduced corabotase, the first molecule in a new class of recombinant neuro-inhibitors, at the SCALE symposium. Phase II trial data show corabotase's safety and efficacy in treating moderate to severe facial wrinkles, including glabellar ...

Market News
4 hours ago
Na
Bullish
news icon
pluang ai news

Choosing between iShares IWM and Vanguard VTWO ETFs depends on trading needs vs. long-term cost savings.

The iShares Russell 2000 ETF (IWM) and Vanguard Russell 2000 ETF (VTWO) both track the same 2,000 small-cap stocks but differ in cost and trading features. IWM offers deep options liquidity and trading efficiency with a higher 0.19% fee, ideal for tr...

Market News
4 hours ago
24/7 Wall Street
Neutral
pluang ai news

Rising fuel prices boost demand for electric vehicles as cost concerns replace idealism

Polestar's CEO Michael Lohscheller said soaring fuel prices due to Middle East tensions have shifted consumer interest from 'range anxiety' to 'pump anxiety,' driving higher demand for electric vehicles (EVs). This change means buyers now prioritize ...

Market News
4 hours ago
CNBC
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $17.18M
  • Sector
    Health
  • 3M Drawdown
    -38.01%
  • Enterprise Value
    $11.29M
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    5 days
$0.69
52W Low: $0.6
29 Apr 2026
52W High: $2.21
03 Jul 2025

Citius Pharmaceuticals Inc (CTXR) is currently valued at a market capitalization of $17.18M, with an enterprise value of $11.29M. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.6 and a high of $2.21, highlighting its annual price range. Over the past three months, Citius Pharmaceuticals Inc has recorded a drawdown of -38.01%, reflecting recent price volatility. On average, investors hold Citius Pharmaceuticals Inc for approximately 5 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!